Loading...
•
Mar 31, 2020
SI-BONE Q1 2020 Earnings Report
Reported financial results for the first quarter of 2020.
Key Takeaways
SI-BONE, Inc. reported a 12% increase in revenue to $16.8 million for Q1 2020, with U.S. revenue up 14% to $15.3 million. The company's operating loss was $11.9 million, and net loss was $12.8 million, or $0.47 per diluted share.
Revenue of $16.8 million for the first quarter 2020, representing a 12% increase over the corresponding period in 2019
U.S. revenue of $15.3 million for the first quarter 2020, representing a 14% increase over the corresponding period in 2019
Received FDA 510(k) clearance for an expanded indication for the iFuse Implant System to support the Company's trauma program
Obtained positive coverage by Health Alliance Plan, a commercial payor in Michigan
SI-BONE
SI-BONE
Forward Guidance
Due to the evolving environment and continued uncertainties from the impact of COVID-19, SI-BONE has withdrawn its previously announced guidance for the full year 2020.